Substituted 4-aryl-1,4-dihydro-1,6-naphthyridinamid es and use thereof

Details for Australian Patent Application No. 2008221071 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Kolkhof, Peter; Barfacker, Lars; Klein, Martina; Nitsche, Adam; Munter, Klaus; Albrecht-Kupper, Barbara; Grosser, Rolf; Schlemmer, Karl-Heinz; Hartmann, Elke

Agent Davies Collison Cave

Pub. Number AU-A-2008221071

PCT Pub. Number WO2008/104306

Priority 10 2007 009 494.0 27.02.07 DE

Filing date 19 February 2008

Wipo publication date 4 September 2008

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

3 September 2009 PCT application entered the National Phase

  PCT publication WO2008/104306 Priority application(s): WO2008/104306

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008221073-Method for the separation of nitrogen from liquefied natural gas

2008221066-Hybrid organic solar cells with photoactive semiconductor nanoparticles enclosed in surface modifiers